BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Staging
11 results:

  • 1. The Expression and Prognostic Significance of ICOS in NSCLC Integrated Pan-cancer and Multi-Omics Analyses.
    Chen M; Yan X; Hong B; Xiao Y; Qian Y
    Int J Med Sci; 2024; 21(5):795-808. PubMed ID: 38616999
    [No Abstract]    [Full Text] [Related]  

  • 2. The prognostic value of a 4-factor neoimmunologic score system in non-small cell lung cancer.
    Yang F; Zeng Z; Li Y; Zhang D; Wei F; Zhao H; Zhang P; Ren X
    J Leukoc Biol; 2022 Dec; 112(6):1605-1619. PubMed ID: 36073781
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Usefulness of
    Li Y; Li Y; Huang Y; Wu X; Yang Z; Wu C; Jiang L
    Ann Nucl Med; 2021 Sep; 35(9):1048-1057. PubMed ID: 34101153
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. foxp3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III.
    Jiang M; Wu C; Zhang L; Sun C; Wang H; Xu Y; Sun H; Zhu J; Zhao W; Fang Q; Yu J; Chen P; Wu S; Zheng Z; He Y; Zhou C
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006632
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Different pattern of PD-L1, IDO, and foxp3 Tregs expression with survival in thymoma and thymic carcinoma.
    Wei YF; Chu CY; Chang CC; Lin SH; Su WC; Tseng YL; Lin CC; Yen YT
    Lung Cancer; 2018 Nov; 125():35-42. PubMed ID: 30429036
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and foxp3 in non-small cell lung cancer.
    Zhao H; Zhang X; Han Z; Xie W; Yang W; Wei J
    Sci Rep; 2018 Jun; 8(1):9847. PubMed ID: 29959381
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.
    Yan X; Jiao SC; Zhang GQ; Guan Y; Wang JL
    Cancer Gene Ther; 2017 Feb; 24(2):57-63. PubMed ID: 28084319
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CD4+, IL17 and foxp3 expression in different pTNM stages of operable non-small cell lung cancer and effects on disease prognosis.
    Zhang GQ; Han F; Fang XZ; Ma XM
    Asian Pac J Cancer Prev; 2012; 13(8):3955-60. PubMed ID: 23098499
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Changes of regulatory T cells and foxp3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. foxp3 and TLR4 protein expression are correlated in non-small cell lung cancer: implications for tumor progression and escape.
    Fu HY; Li C; Yang W; Gai XD; Jia T; Lei YM; Li Y
    Acta Histochem; 2013 Mar; 115(2):151-7. PubMed ID: 22749378
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical significance of tumor interstitial T lymphocyte subset activity in non-small-cell lung cancer].
    Xue L; Chen J; Peng JZ; Chen BS; Hua P; Yang YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2456-8. PubMed ID: 20034901
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.